Underwriting AgreementUnderwriting Agreement • January 25th, 2010 • Biocurex Inc • Surgical & medical instruments & apparatus • Oregon
Introductory. BioCurex, Inc., f/k/a Whispering Oaks International, Inc., a Texas corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 1,200,000 Units, each Unit consisting of (i) 70 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), and (ii) 70 warrants, each to purchase one share of Common Stock (each a “Unit Warrant”, collectively, the “Unit Warrants”). The Unit Warrants are to be issued under the terms of a Warrant Agreement (the “Warrant Agreement”) by and between the Company and Securities Transfer Corporation, as warrant agent (the “Warrant Agent”), substantially in the form most recently filed as an exhibit to the Registration Statement (hereinafter defined). The 1,200,000 Units to be sold by the Company are collectively called the “Firm Units”. In addition, the Company has granted to the Underwriters an option to purchase up to an additional 180,000 Units (the
Form of STOCK OPTION AGREEMENTStock Option Agreement • January 25th, 2010 • Biocurex Inc • Surgical & medical instruments & apparatus
STOCK OPTION AGREEMENT (hereinafter called this “Agreement”) made as of the 22nd day of January, 2010 between BioCurex, Inc., a Texas corporation (hereinafter called the “Corporation”), and ____________ (hereinafter called the “Optionee”).
